Akoum A

No ORCID on file · 56 papers in corpus · active 1995-2016

Study types

  • article 42
  • other 13
  • review 1

Condition tags

  • endometriosis 56
  • infertility 9
  • chronic_pelvic_pain 5
  • dysmenorrhea 1
  • dyspareunia 1
article 2016
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2016-1569

CONTEXT: is a potent angiogenic factor in endothelial cells. OBJECTIVE: We sought to determine whether or not the F-prostanoid receptor modulates angiogenesis in ectopic stromal cells. DESIGN: signaling was assessed. SETTING: The study was …

other 2016
Journal of reproductive immunology ·doi:10.1016/j.jri.2016.01.005

Studies have long sought specific cytokines that could characterize endometriosis. Either due to variations between study designs regarding the assessment criteria for the cytokine or to low power resulting from small sample size, no factor…

article 2015
BioMed research international ·doi:10.1155/2015/808146

OBJECTIVE: To investigate the level of expression of prostaglandin receptivity and uptake factors in eutopic and ectopic endometrium of women with endometriosis. DESIGN: Prospective study. SETTING: Human reproduction research laboratory. PA…

article 2015
Medecine sciences : M/S ·doi:10.1051/medsci/20153110003

Le facteur inhibant la migration des macrophages, une cytokine cle dans l’endometriose Ali Akoum1,2, Khaled Khoufache1 1Laboratoire d’endocrinologie de la reproduction, centre de recherche, hopital Saint-Francois d’Assise, CHUQ, universite …

article 2015
Molecular human reproduction ·doi:10.1093/molehr/gav056

STUDY HYPOTHESIS: Selective activation or blockade of the prostaglandin (PG) F2α receptor (FP receptor) affects ectopic endometrial tissue growth and endometriosis development. STUDY FINDING: FP receptor antagonists might represent a promis…

article 2014
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-12-51

BACKGROUND: A deficiency in the counter-regulatory mechanisms of interleukin 1 (IL1) may play a significant role in endometriosis pathogenesis and associated chronic inflammation. The aim of this study was to investigate peripheral blood le…

article 2014
PloS one ·doi:10.1371/journal.pone.0110434

Pelvic inflammation is a hallmark of endometriosis pathogenesis and a major cause of the disease's symptoms. Abnormal immune and inflammatory changes may not only contribute to endometriosis-major symptoms, but also contribute to ectopic en…

article 2013
Medecine sciences : M/S ·doi:10.1051/medsci/20132912012
article 2013
Fertility and sterility ·doi:10.1016/j.fertnstert.2013.08.016

ObjectiveTo investigate prostaglandin (PG) biosynthesis and catabolism pathways in eutopic and ectopic endometrium of women with endometriosis.DesignRetrospective study.SettingHuman reproduction research laboratory.Patient(s)Forty-five wome…

article 2012
Minerva endocrinologica

Defined by the presence of endometrial-like cells outside the uterus, endometriosis is one of the most diagnosed gynecological disorders, affecting 5 to 10 % of reproductive age women, but the true incidence is unknown. Endometriosis is a m…

article 2012
PloS one ·doi:10.1371/journal.pone.0037264

Endometriosis, a disease of reproductive age women, is a major cause of infertility, menstrual disorders and pelvic pain. Little is known about its etiopathology, but chronic pelvic inflammation is a common feature in affected women. Beside…

article 2012
The American journal of pathology ·doi:10.1016/j.ajpath.2012.05.018

Immune-endocrine interplay may play a major role in the pathogenesis of endometriosis. In the present study, we have investigated the interaction between macrophage migration inhibitory factor (MIF), a major pro-inflammatory and growth-prom…

other 2012
The American journal of pathology ·doi:10.1016/j.ajpath.2012.06.022

Endometriosis is often associated with a chronic pelvic immuno-inflammatory process, which is closely related to disease pathogenesis and major symptoms. Our studies led to the detection of a marked imbalance between IL-1 and its natural in…

article 2011
Journal of reproductive immunology ·doi:10.1016/j.jri.2011.08.001

Interleukin 1 (IL1) may play an important role in endometriosis-associated pelvic inflammation, and natural specific inhibitors, including soluble IL1 receptor accessory protein (sIL1RAcP) and soluble IL1 receptor type 2 (sIL1R2), are criti…

article 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.12.056

ObjectiveTo investigate interleukin (IL) 1 receptor accessory protein (IL1RAcP) expression in the eutopic endometrium of women with endometriosis.DesignRetrospective study.SettingHuman reproduction research laboratory.Patient(s)Sixty-six wo…

other 2010
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2010-0417

CONTEXT: An active angiogenesis is required for ectopic endometrial tissue growth. Our previous studies led to the identification of macrophage migration inhibitory factor (MIF), which is markedly elevated in active, vascularized, and early…

review 2009
Frontiers in bioscience (Elite edition) ·doi:10.2741/E38

Endometriosis is defined as the presence of ectopic endometrial-like tissue outside the uterus cavity. This disease, afflicting women during their reproductive age, is mainly associated with pelvic pain and infertility. Sampson's theory whi…

article 2009
Endocrinology ·doi:10.1210/en.2008-1088

Cyclooxygenase (COX) is the rate-limiting enzyme in the metabolic conversion of arachidonic acid to prostaglandins (PGs), including prostaglandin E(2) (PGE(2)), a major mediator of inflammation and angiogenesis. Herein, we report that macro…

other 2008
Journal of reproductive immunology ·doi:10.1016/j.jri.2007.04.002

Interleukin-1 (IL1) is believed to play a central role in the immuno-inflammatory process associated with endometriosis. IL1 triggers cell activation via its receptor type I (IL1R1), but its receptor type II (IL1R2) is known instead as a sc…

other 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.06.019

OBJECTIVE: To evaluate the levels of interleukin-1beta (IL1beta) and its inhibitory soluble interleukin-1 receptor type II (IL1R2) in the peritoneal fluid (PF) of normal women and patients with endometriosis suffering from pelvic pain and i…

article 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.05.017

ObjectiveTo investigate the involvement of the nuclear factor (NF)-kappaB in the interleukin (IL)-1 beta-mediated macrophage migration inhibitory factor (MIF) gene activation.DesignProspective study.SettingHuman reproduction research labora…

article 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.04.002

ObjectiveTo evaluate the effect of macrophage migration inhibitory factor (MIF) on sperm capacitation, a maturational process that occurs in the female reproductive tract and enables spermatozoa to become fully competent at fertilizing the …

article 2007
Human Reproduction ·doi:10.1093/humrep/dem021

BACKGROUND: The ectopic establishment and progression of endometrial tissue is dependent upon its interaction with and responsiveness to the stimuli present in its new environment. Immune cell-derived cytokines, such as interleukin 1 (IL1),…

article 2007
Reproduction (Cambridge, England) ·doi:10.1530/rep.1.01121

Abstract The establishment and progression of ectopic endometrial implants are dependent upon their interaction with and responsiveness to the stimuli present in their new environment. According to our and other previous studies, immune cel…

article 2007
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/j.1600-0897.2007.00471.x

PROBLEM: Macrophage migration inhibitory factor (MIF), a potent immuno-modulatory, angiogenic and tissue remodeling factor, is markedly expressed in ectopic endometrial implants and may play key role in the capability of this tissue to grow…